Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore , and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestones The Eppendorf Group has signed a partnership agreement with NSG BioLabs to support biotech startups in their R&D efforts in Singapore SINGAPORE , June 13, 2024 /PRNewswire/ -- NSG BioLabs , Singapore's largest provider of biotech co-working laboratory and office space, announces a new partnership with Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, to support biotech startups by providing needed resources such as product and applications expertise and its networks to advance startup research and development (R&D). Since 2019, NSG BioLabs has been assisting innovators in creating impactful solutions in the health, biomedical, agrifood, and industrial biotechnology sectors, working in areas such as precision medicine, nucleic acids, AI-enabled drug discovery, synthetic biology, and other impactful areas. With the largest co-working biotech laboratory and office footprint in Singapore , coupled with extensive networks with local and international partners, suppliers, and industry experts, NSG BioLabs has helped over 40 companies as residents.
The company's residents include several multi-billion-dollar multin.